Invention Grant
- Patent Title: Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
-
Application No.: US11600332Application Date: 2006-11-15
-
Publication No.: US07842815B2Publication Date: 2010-11-30
- Inventor: Alfredo C. Castro , Edward B. Holson , Brian T. Hopkins , Nii O. Koney , Daniel A. Snyder , Thomas T. Tibbitts
- Applicant: Alfredo C. Castro , Edward B. Holson , Brian T. Hopkins , Nii O. Koney , Daniel A. Snyder , Thomas T. Tibbitts
- Applicant Address: US MA Cambridge
- Assignee: Infinity Pharmaceuticals, Inc.
- Current Assignee: Infinity Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Foley Hoag LLP
- Main IPC: C07D261/02
- IPC: C07D261/02
Abstract:
One aspect of the present invention relates to heterocyclic compounds that bind to bcl proteins and inhibit Bcl function. Another aspect of the present invention relates to compositions comprising a heterocyclic compound of the invention. The present invention provides methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Public/Granted literature
- US20080306127A9 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Public/Granted day:2008-12-11
Information query
